A AARDVARK THERAPEUTICS
Live / Allowed — Notice of allowance issued (as of 23 Sept 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 17 Nov 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98857689
- Mark type
- Design + words
- Filed
- 17 Nov 2024
- Published for opposition
- 29 Jul 2025
- Attorney of record
- Elise Wu
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic pharmaceuticals for the treatment of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity; therapeutic pharmaceuticals for cancer treatment and management; abuse-deterrent pharmaceutical preparations for treatment of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity
- Class 042 — Scientific and technological services: Medical and scientific research and development in the fields of diagnosis and treatment of neuro-psychological disorders, autism, metabolic and inflammatory conditions, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity; providing medical and scientific research information in the fields of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity; medical and scientific research, namely, conducting clinical trials for others for pharmaceuticals, drug development, and therapeutic applications in the fields of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity; clinical research in the field of neuro-psychological disorders, autism, metabolic and inflammatory diseases, and obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity
Owner
- AARDVARK THERAPEUTICS, INC., San Diego, CA, US
- AARDVARK THERAPEUTICS, INC., San Diego, CA, US
Prosecution history
- 01 Apr 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 01 Apr 2026 — ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
- 01 Apr 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Mar 2026 — TEAS STATEMENT OF USE RECEIVED
- 23 Mar 2026 — TEAS REQUEST TO DIVIDE RECEIVED
- 23 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 23 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 29 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Jul 2025 — PUBLISHED FOR OPPOSITION
- 23 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 Jun 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 23 Jun 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 23 Jun 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 14 May 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED